DOI 10.1016/j.ijbiomac.2025.145769
Antibacterial, anti-inflammatory and anti-osteoclastogenic effects of synthetic mineralized lysozyme nanoparticles for treating infectious osteoporosis.
Аннотация
Lipopolysaccharide (LPS) induces inflammation and bone loss by promoting osteoclast formation. While nanohydroxyapatite (nHA) is widely used for bone grafting due to its biocompatibility and osteoconductive properties, its antibacterial and anti-inflammatory functions are limited. Lysozyme, a natural enzyme with antibacterial, anti-inflammatory, and antioxidant properties, was immobilized onto polyglutamate-conjugated nHA (e.nHA) via co-precipitation to create a novel material: mineralized lysozyme (L-e.nHA). Compared to nHA, e.nHA showed enhanced lysozyme adsorption, following the Langmuir isotherm, with optimal immobilization between 0.5 and 1 mg/mL. Characterization confirmed successful L-e.nHA synthesis. Antibacterial assays demonstrated 100 % and 80 % inhibition of Escherichia coli and Staphylococcus aureus, respectively. L-e.nHA significantly modulated cytokine expression by downregulating proinflammatory genes (Tnfα, Il-6) and upregulating immunoregulatory genes (Il10, Tgfb1) via the JNK1/2 pathway. Additionally, it reduced LPS-induced expression of osteoclastogenic genes (Trap, Dcstamp, Cathepsin K) and the number of TRAP-positive multinucleated cells. These findings suggest that L-e.nHA is a promising therapeutic material with dual antibacterial and anti-osteoclastogenic functions, offering potential for treating bone infections and mitigating osteoporosis.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.